CBT
IBB icon

Crews Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Crews Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.8K Hold
330
– – 0.01% 336
2026
Q1 		$55.7K Hold
330
– – 0.01% 350
2025
Q4 		$55.7K Hold
330
– – 0.01% 346
2025
Q3 		$47.6K Hold
330
– – 0.01% 369
2025
Q2 		$41.7K Hold
330
– – 0.01% 373
2025
Q1 		$42.2K Hold
330
– – 0.01% 362
2024
Q4 		$43.6K Buy
+330
New +$46.4K 0.01% 360

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Crews Bank & Trust's IBB Position: Q2 2026 in Review

Crews Bank & Trust held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 330 shares worth $62.8K. The position accounts for 0.01% of the portfolio, ranked #336.

Crews Bank & Trust first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Crews Bank & Trust held 330 shares of iShares Biotechnology ETF worth $62.8K as of Q2 2026.
  • Crews Bank & Trust left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #336 holding.
  • Crews Bank & Trust first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.